Literature DB >> 10643710

Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I.

N Di Simone1, P L Meroni, N de Papa, E Raschi, D Caliandro, C S De Carolis, M A Khamashta, T Atsumi, G R Hughes, G Balestrieri, A Tincani, P Casali, A Caruso.   

Abstract

OBJECTIVE: To investigate the in vitro ability of antiphospholipid antibodies (aPL) to bind human trophoblast cells and to affect gonadotropin secretion and invasiveness.
METHODS: Antiphospholipid antibody IgG from women with recurrent miscarriages, beta2-glycoprotein I (beta2GPI)-independent IgG aPL human monoclonal antibody (mAb) (519), and IgM anti-beta2GPI human mAb (TMIG2) were investigated for their binding to trophoblasts cultured for various amounts of time, their ability to affect invasiveness of Matrigel-coated filters, and their release of human chorionic gonadotropin (hCG).
RESULTS: Polyclonal IgG aPL, as well as mAb 519 and TMIG2, bound to trophoblasts, the highest binding being found when cells displayed the greatest amount of syncytium formation. TM1G2 binding was found to be betaGPI dependent. Both polyclonal and monoclonal aPL, but not the controls, significantly reduced hCG release and Matrigel invasiveness.
CONCLUSION: These findings suggest that aPL recognition of both anionic PL and adhered beta2GPI on trophoblast cell structures might represent a potential pathogenetic mechanism for defective placentation in women with the antiphospholipid syndrome.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10643710      PMCID: PMC4625538          DOI: 10.1002/1529-0131(200001)43:1<140::AID-ANR18>3.0.CO;2-P

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  51 in total

1.  Special report. The Second International Anti-cardiolipin Standardization Workshop/the Kingston Anti-Phospholipid Antibody Study (KAPS) group.

Authors:  E N Harris
Journal:  Am J Clin Pathol       Date:  1990-10       Impact factor: 2.493

2.  The plasma cofactor and anticardiolipin antibodies.

Authors:  F Allegri; G Balestrieri; R Cattaneo; M Martinelli; A Tincani; W Barcellini; N Del Papa; P L Meroni; M Falco; F L Luan
Journal:  Clin Exp Rheumatol       Date:  1990 Nov-Dec       Impact factor: 4.473

3.  Anti-mitochondrial M5 type antibody represents one of the serological markers for anti-phospholipid syndrome distinct from anti-cardiolipin and anti-beta2-glycoprotein I antibodies.

Authors:  L La Rosa; G Covini; C Galperin; L Catelli; N Del Papa; G Reina; A Morabito; G Balestrieri; A Tincani; M E Gershwin; P L Meroni
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

4.  Pregnancy loss and autoantibodies against phospholipid-binding proteins.

Authors:  C R Falcón; M E Martinuzzo; R R Forastiero; G S Cerrato; L O Carreras
Journal:  Obstet Gynecol       Date:  1997-06       Impact factor: 7.661

5.  Purification, characterization, and in vitro differentiation of cytotrophoblasts from human term placentae.

Authors:  H J Kliman; J E Nestler; E Sermasi; J M Sanger; J F Strauss
Journal:  Endocrinology       Date:  1986-04       Impact factor: 4.736

6.  Pregnancy loss in the antiphospholipid-antibody syndrome--a possible thrombogenic mechanism.

Authors:  J H Rand; X X Wu; H A Andree; C J Lockwood; S Guller; J Scher; P C Harpel
Journal:  N Engl J Med       Date:  1997-07-17       Impact factor: 91.245

7.  Anti-beta 2-glycoprotein I antibodies: a useful marker for the antiphospholipid syndrome.

Authors:  M Teixidó; J Font; J C Reverter; R Cervera; D Tàssies; M Ingelmo; G Escolar; A Ordinas
Journal:  Br J Rheumatol       Date:  1997-01

8.  Differential effects of anti-beta2-glycoprotein I antibodies on endothelial cells and on the manifestations of experimental antiphospholipid syndrome.

Authors:  J George; M Blank; Y Levy; P Meroni; M Damianovich; A Tincani; Y Shoenfeld
Journal:  Circulation       Date:  1998-03-10       Impact factor: 29.690

Review 9.  Immune recognition at the maternal-fetal interface: overview.

Authors:  J A McIntyre
Journal:  Am J Reprod Immunol       Date:  1992 Oct-Dec       Impact factor: 3.886

10.  A sensitive test demonstrating lupus anticoagulant and its behavioural patterns.

Authors:  T Exner; K A Rickard; H Kronenberg
Journal:  Br J Haematol       Date:  1978-09       Impact factor: 6.998

View more
  39 in total

Review 1.  Complement activation as a mediator of antiphospholipid antibody induced pregnancy loss and thrombosis.

Authors:  J E Salmon; G Girardi; V M Holers
Journal:  Ann Rheum Dis       Date:  2002-11       Impact factor: 19.103

Review 2.  Update on the management of the pregnant patient with antiphospholipid antibody.

Authors:  L R Sammaritano
Journal:  Curr Rheumatol Rep       Date:  2001-06       Impact factor: 4.592

Review 3.  Antiphospholipid syndrome: multiple mechanisms.

Authors:  C G Mackworth-Young
Journal:  Clin Exp Immunol       Date:  2004-06       Impact factor: 4.330

4.  ApoE Receptor 2 Mediation of Trophoblast Dysfunction and Pregnancy Complications Induced by Antiphospholipid Antibodies in Mice.

Authors:  Jane E Salmon; Chieko Mineo; Victoria Ulrich; Shari E Gelber; Milena Vukelic; Anastasia Sacharidou; Joachim Herz; Rolf T Urbanus; Philip G de Groot; David R Natale; Anirudha Harihara; Patricia Redecha; Vikki M Abrahams; Philip W Shaul
Journal:  Arthritis Rheumatol       Date:  2016-03       Impact factor: 10.995

5.  Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss.

Authors:  Eva N Hamulyák; Luuk Jj Scheres; Mauritia C Marijnen; Mariëtte Goddijn; Saskia Middeldorp
Journal:  Cochrane Database Syst Rev       Date:  2020-05-02

Review 6.  Intravenous immunoglobulin therapy in antiphospholipid syndrome.

Authors:  Emiliana Konova
Journal:  Clin Rev Allergy Immunol       Date:  2005-12       Impact factor: 8.667

7.  Enhancement of trophoblast differentiation and survival by low molecular weight heparin requires heparin-binding EGF-like growth factor.

Authors:  Alan D Bolnick; Jay M Bolnick; Hamid-Reza Kohan-Ghadr; Brian A Kilburn; Omar J Pasalodos; Pankaj K Singhal; Jing Dai; Michael P Diamond; D Randall Armant; Sascha Drewlo
Journal:  Hum Reprod       Date:  2017-06-01       Impact factor: 6.918

Review 8.  Antiphospholipid antibody-mediated reproductive failure in antiphospholipid syndrome.

Authors:  Miri Blank; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2010-04       Impact factor: 8.667

Review 9.  The journey of antiphospholipid antibodies from cellular activation to antiphospholipid syndrome.

Authors:  Rohan Willis; E B Gonzalez; A R Brasier
Journal:  Curr Rheumatol Rep       Date:  2015-03       Impact factor: 4.592

10.  Pathogenic role of anti-beta 2-glycoprotein I antibodies in antiphospholipid associated fetal loss: characterisation of beta 2-glycoprotein I binding to trophoblast cells and functional effects of anti-beta 2-glycoprotein I antibodies in vitro.

Authors:  N Di Simone; E Raschi; C Testoni; R Castellani; M D'Asta; T Shi; S A Krilis; A Caruso; P L Meroni
Journal:  Ann Rheum Dis       Date:  2004-07-15       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.